29 October 2022
Allen Young
Robocentric CEO
The transhumanistic Asian-American Man
Biotech researchers will be very limited in number; biotech research is not where a lot of human jobs will be created in biotech.
What human beings excel in is consumption and producing means for consumption using their brains, hands, and legs: that human excellence must be used in creating an enormous number of human jobs in biotech.
The greatest markets in biotech are in consumer, industrial, and medical biomanufactured materials consumption; the greatest numbers of human jobs in biotech can be in biotech-made materials consumption increase tools or means creation using human creativity, such as biotech-made materials usage processes development for construction and manufacturing and crafting, and biotech-made materials containing products development and marketing and sales.
That is, just like in robotics and AI, the greatest numbers of human jobs are in applied, not core, biotech. Core biotech is developing and marketing biotechnologies; applied biotech is using biotechnologies or biotech-made materials for commercial purposes. (Core robotics is developing and marketing the robotics software and hardware technologies; applied robotics is using robot technologies for commercial purposes.)
Robocentric does research and development in biotech, for microscopically and nanoscopically 3D-scanning human bodies, and doing biochemical analysis on human biomatter, and also for mass-biomanufacturing consumer, industrial, and medical materials using input biomatter such as cotton for creating fortified cotton and other biomanufactured materials.
Robocentric biotech advances the scientific knowledge on the human body, for advancing artificial intelligence, robotics, human longevity biotech, and biomedicines; Robocentric also advances biotech for creating and increasing human consumption of biotech-made consumer and industrial and medical materials and bioelectronics.
Robocentric aims for systematically creating a trillion U.S. dollar economy of biomanufactured-materials production and consumption.
In order to create a one-trillion U.S. dollar biomanufactured materials annual economy, 300 million people need to buy US3,600 worth of biomanufactured materials per year, or US$300 worth of biomanufactured materials per month. Creating this biotech economy is one goal Robocentric pursues and strives to accomplish through developing, mass-manufacturing, and marketing biomanufactured materials.
Robocentric also aims for creating a multi-billion U.S. dollar economy of bioelectronic hardware components and devices production and consumption.